SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-028775
Filing Date
2022-03-01
Accepted
2022-03-01 17:08:21
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-3 tm227351-1_s3.htm S-3 549509
2 EXHIBIT 1.2 tm227351d2_ex1-2.htm EX-1.2 226659
3 EXHIBIT 4.2 tm227351d2_ex4-2.htm EX-4.2 331649
4 EXHIBIT 4.4 tm227351d2_ex4-4.htm EX-4.4 119357
5 EXHIBIT 4.5 tm227351d2_ex4-5.htm EX-4.5 122140
6 EXHIBIT 4.6 tm227351d2_ex4-6.htm EX-4.6 107048
7 EXHIBIT 5.1 tm227351d2_ex5-1.htm EX-5.1 32733
8 EXHIBIT 23.1 tm227351d2_ex23-1.htm EX-23.1 2691
9 EX-FILING FEES tm227351d2_ex-filingfees.htm EX-FILING FEES 50742
10 GRAPHIC lg_caratmtherap-4c.jpg GRAPHIC 39308
11 GRAPHIC image_001.jpg GRAPHIC 9812
12 GRAPHIC image_002.jpg GRAPHIC 10004
13 GRAPHIC image_003.jpg GRAPHIC 10004
14 GRAPHIC image_004.jpg GRAPHIC 10004
15 GRAPHIC image_005.jpg GRAPHIC 10004
  Complete submission text file 0001104659-22-028775.txt   1667269
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263165 | Film No.: 22699524
SIC: 2834 Pharmaceutical Preparations